{"id":382802,"date":"2020-11-17T08:03:30","date_gmt":"2020-11-17T13:03:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382802"},"modified":"2020-11-17T08:03:30","modified_gmt":"2020-11-17T13:03:30","slug":"biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/","title":{"rendered":"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MISSISSAUGA, Ontario, Nov.  17, 2020  (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, \u201cthe Company\u201d, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2020 on Thursday, November 26, 2020. A presentation on the Company\u2019s third quarter and year-to-date 2020 results by Ren\u00e9 Goehrum, BioSyent President and CEO, will also be available on the Company\u2019s website on the date of release.<\/p>\n<p align=\"justify\">\n        <strong>About BioSyent Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Listed on the TSX Venture Exchange under the trading symbol \u201cRX\u201d, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty\/hospital and international business units.<\/p>\n<p align=\"justify\">As of the date of this press release, the Company has 12,808,600 common shares outstanding.<\/p>\n<p align=\"justify\">For a direct market quote for the TSX Venture Exchange and other Company financial information please visit <a href=\"http:\/\/www.tmxmoney.com\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.tmxmoney.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>For further information please contact:<\/strong>\n      <\/p>\n<p align=\"justify\">Mr. Ren\u00e9 C. Goehrum<br \/>President and CEO<br \/>BioSyent Inc.<br \/>E-Mail: <a href=\"mailto:investors@biosyent.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@biosyent.com<\/a><br \/>Phone: 905-206-0013<br \/>Web: www.biosyent.com<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/643be588-2755-47a8-a30d-6d9fbf3e03a5\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MISSISSAUGA, Ontario, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, \u201cthe Company\u201d, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2020 on Thursday, November 26, 2020. A presentation on the Company\u2019s third quarter and year-to-date 2020 results by Ren\u00e9 Goehrum, BioSyent President and CEO, will also be available on the Company\u2019s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol \u201cRX\u201d, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-382802","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MISSISSAUGA, Ontario, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, \u201cthe Company\u201d, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2020 on Thursday, November 26, 2020. A presentation on the Company\u2019s third quarter and year-to-date 2020 results by Ren\u00e9 Goehrum, BioSyent President and CEO, will also be available on the Company\u2019s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol \u201cRX\u201d, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives &hellip; Continue reading &quot;BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T13:03:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020\",\"datePublished\":\"2020-11-17T13:03:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/\"},\"wordCount\":205,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/\",\"name\":\"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=\",\"datePublished\":\"2020-11-17T13:03:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/","og_locale":"en_US","og_type":"article","og_title":"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020 - Market Newsdesk","og_description":"MISSISSAUGA, Ontario, Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, \u201cthe Company\u201d, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2020 on Thursday, November 26, 2020. A presentation on the Company\u2019s third quarter and year-to-date 2020 results by Ren\u00e9 Goehrum, BioSyent President and CEO, will also be available on the Company\u2019s website on the date of release. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol \u201cRX\u201d, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives &hellip; Continue reading \"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T13:03:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020","datePublished":"2020-11-17T13:03:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/"},"wordCount":205,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/","name":"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=","datePublished":"2020-11-17T13:03:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4Njk0MiMzODI5NjI4IzIwODk2Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosyent-schedules-q3-and-ytd-2020-earnings-release-for-november-26-2020\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioSyent Schedules Q3 and YTD 2020 Earnings Release for November 26, 2020"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=382802"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382802\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=382802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=382802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=382802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}